Securities code: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) securities abbreviation: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) Announcement No.: 2022029
Bond Code: 127057 bond abbreviation: Panlong convertible bond
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Special report on the deposit and use of raised funds in 2021
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
In accordance with the relevant provisions of the regulatory guidelines for listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022) (CSRC announcement [2022] No. 15) and the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board issued by the China Securities Regulatory Commission, Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) (hereinafter referred to as “the company”) the board of directors prepared the special report on the deposit and actual use of raised funds in 2021 as of December 31, 2021. The relevant information is hereby announced as follows:
1、 Basic information of raised funds
With the approval of zjxk [2017] No. 1875 document of China Securities Regulatory Commission, the company made an initial public offering of 21.67 million RMB common shares (A shares) on November 8, 2017, with an issue price of 10.03 yuan per share and a total raised capital of 21735010000 yuan, Zhongtai Securities Co.Ltd(600918) remitted to the company on November 8, 2017 to open a bank account of RMB 11035000000 of Bank Of China Limited(601988) Xi’an Taibai community sub branch with an account number of 102471368418; The bank account opened in Bank Of China Limited(601988) Xi’an Taibai community sub branch with account number of 102071367372 is 3661590000 yuan; The bank account with account number 102471368509 opened in Bank Of China Limited(601988) Xi’an Taibai community sub branch is 233320000 yuan; The bank account with the account number of 102071367418 opened in Bank Of China Limited(601988) Xi’an Taibai community sub branch is 2705400000 yuan; A total of 19735010000 yuan was remitted (after deducting the underwriting expenses of the underwriter of 1800000000 yuan, the recommendation expenses of the recommendation institution of 200000000 yuan, and the total expenses excluding tax of 1886792453 yuan), after deducting other issuance expenses directly related to the issuance of equity securities, excluding tax of 1443396226 yuan, the net amount of raised funds was 18404821321 yuan.
It was verified by Lixin Certified Public Accountants (special general partnership) and issued a capital verification report (xksbz [2017] No. zf10909).
2、 Deposit and management of raised funds
In order to standardize the management and use of the raised funds, improve the efficiency and efficiency of the use of funds and protect the rights and interests of investors, the company, in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China and the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of the raised funds of listed companies In accordance with the provisions of relevant laws, regulations and normative documents such as the guidelines for the standardized operation of small and medium-sized board listed companies of Shenzhen Stock Exchange (revised in 2015), and in combination with the actual situation of the company, the raised funds management system has been formulated to implement the special account storage management of the raised funds.
The company signed the tripartite supervision agreement on raised funds with the sponsor Zhongtai Securities Co.Ltd(600918) and Bank Of China Limited(601988) Xi’an high tech Development Zone sub branch on December 3, 2017, and the company has strictly complied with the agreement when using the raised funds.
3、 Actual use of raised funds
(I) use amount and current balance of raised funds
In 2021, the company used 5624885729 yuan of raised funds, including 47038370 yuan for marketing network expansion and information system upgrading construction projects, 1298850332 yuan for R & D center expansion projects and 4278997027 yuan for production line expansion projects.
As of December 31, 2021, the company has used a total of 15320360766 yuan of raised funds, and the unused raised funds are 4828340066 yuan (including the net amount of 1743879511 yuan from the purchase of wealth management income and the accumulated received bank deposit interest minus bank handling charges), including: (1) 1028340066 yuan deposited in the special account for raised funds; (2) The fixed deposit deposited in Bank Of Xi’An Co.Ltd(600928) unit is 3800000000 yuan, and the interest settled is 127163801 yuan, which will be automatically transferred with the principal to the next cycle.
(II) actual use of raised funds in the current period
See the attached table comparison table of the use of raised funds for details.
(III) changes in the implementation subject and location of the project invested by raised funds
The company does not have any change in the implementation subject and place of the investment project.
(IV) advance investment and replacement of investment projects with raised funds
There is no advance investment and replacement of the company’s raised funds.
(V) storage of raised funds in special account
As of December 31, 2021, the deposit of the company’s special account for raised funds is as follows:
Opening bank account category account closing balance (yuan) remarks
The special account for raised funds 102471368418806110937 is used for production line expansion projects
The special account for raised funds of Bank of China 102071367372110477729 is used for the expansion project of R & D center in Xi’an
Taibai small raised funds special account 102471368509111751400 is used for marketing network expansion and Information District sub branch interest system upgrading and construction project
The special account for raised funds 1020713674180.00 is used to supplement working capital
Subtotal: 1028340066
4、 Change the use of funds for investment projects with raised funds
During the reporting period, there was no change in the investment project of the company’s raised funds.
5、 Problems in the use and disclosure of raised funds
This year, there were no major problems in the use and disclosure of the company’s raised funds.
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) board of directors April 26, 2022
Schedule 1:
Comparison table of use of raised funds
Prepared by: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) unit: Yuan
56,24885729
Total amount of raised funds 18404821321 total amount of raised funds invested in this year
The total amount of raised funds for changing purposes is 0.00, and the total amount of raised funds invested has been 15320360766
The proportion of total raised funds with changed purposes is 0.00
Deadline
Changed items
Whether the project invested at the end of the year has reached the expected project feasibility goal, including part of the commitment of raised funds. As of the end of the period, the cumulative investment amount as of the end of the period has been paid in this year
The progress of the total investment amount of the current year after the adjustment of the committed investment project (%) from the available state date to whether there is any major change (e.g. the current benefit of the total investment amount (1) (2))
(3) = great changes in benefits in the current period
(yes)
(2)/(1)
427899702711210937560 101.59 temporary property since the commencement of the project
Production line expansion project no 110350 Ping An Bank Co.Ltd(000001) 10350 Ping An Bank Co.Ltd(000001) 1035000000 no no
18 months from the date of birth
12,98850332 21,493447.50 5
